{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:02:41Z","timestamp":1778914961388,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bbapap.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T18:56:40Z","timestamp":1470855400000},"page":"1548-1557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The allergen Mus m 1.0102: Dissecting the relationship between molecular conformation and allergenic potency"],"prefix":"10.1016","volume":"1864","author":[{"given":"Elena","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Casali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuele E.","family":"Burastero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Spisni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thelma A.","family":"Pertinhez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2016.08.003_bb0005","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1110\/ps.0204202","article-title":"Pheromone binding by polymorphic mouse major urinary proteins","volume":"11","author":"Sharrow","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.peptides.2003.12.025","article-title":"Urinary proteins and the modulation of chemical scents in mice and rats","volume":"25","author":"Beynon","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20050404","article-title":"Structural and functional differences in isoforms of mouse major urinary proteins: a male-specific protein that preferentially binds a male pheromone","volume":"391","author":"Armstrong","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bbrc.2009.10.133","article-title":"The binding cavity of mouse major urinary protein is optimised for a variety of ligand binding modes","volume":"390","author":"Pertinhez","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaci.2004.04.028","article-title":"Environmental detection of mouse allergen by means of immunoassay for recombinant Mus m 1.0102","volume":"114","author":"Ferrari","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaci.2004.02.034","article-title":"Mouse allergen exposure and mouse skin test sensitivity in suburban, middle-class children with asthma","volume":"113","author":"Matsui","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaci.2006.12.663","article-title":"Mouse allergen-specific antibody responses in inner-city children with asthma","volume":"119","author":"Matsui","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00076","article-title":"Animal allergens and their presence in the environment","volume":"5","author":"Zahradnik","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"Position paper - international consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.12.1299","article-title":"Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future","volume":"137","author":"Valenta","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1398-9995.2011.02669.x","article-title":"European Academy of Allergy and Clinical Immunology task force report on \u2018dose-response relationship in allergen-specific immunotherapy\u2019","volume":"66","author":"Calder\u00f3n","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.bbapap.2016.08.003_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000096113","article-title":"Highlights in cellular and molecular mechanisms of allergic diseases. XXVth Congress of the European Academy of Allergology and Clinical Immunology in Vienna","volume":"142","author":"Basinski","year":"2007","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.bbapap.2016.08.003_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1939-4551-6-17","article-title":"A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics","volume":"6","author":"Canonica","year":"2013","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0075","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2008.09.017","article-title":"Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis","volume":"122","author":"Pauli","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri824","article-title":"The future of antigen-specific immunotherapy of allergy","volume":"2","author":"Valenta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000327551","article-title":"In search of a vaccine for mouse allergy: Significant reduction of Mus m 1.0102 allergenicity by structure-guided single-point mutations","volume":"157","author":"Ferrari","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1046\/j.1432-1327.1999.00984.x","article-title":"Solution structure of a recombinant mouse major urinary protein","volume":"266","author":"L\u00fccke","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0095","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1042\/BST20140082","article-title":"Comparative study of the molecular variation between \u2018central\u2019 and \u2018peripheral\u2019 MUPs and significance for behavioural signaling","volume":"42","author":"Phelan","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1021\/bi0362469","article-title":"A recombinant C121S mutant of bovine beta-lactoglobulin is more susceptible to peptic digestion and to denaturation by reducing agents and heating","volume":"43","author":"Jayat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1745-7270.2008.00426.x","article-title":"Expression and purification of cysteine mutation isoforms of rat lipocalin-type prostaglandin D synthase for nuclear magnetic resonance study","volume":"40","author":"Jiafu","year":"2008","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(96)01436-6","article-title":"Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant mouse major urinary protein","volume":"401","author":"Ferrari","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0115","unstructured":"Malvern Instruments White Paper, Dynamic light scattering - Common terms defined."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2222.2006.02618.x","article-title":"Mediator release assays based on human or murine immunoglobulin E in allergen standardization","volume":"37","author":"Kaul","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2009.01.070","article-title":"Mediator release assay for assessment of biological potency of German cockroach allergen extracts","volume":"123","author":"Nowak-Wegrzyn","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.157.1.221","article-title":"High-affinity oligonucleotide ligands to human IgE inhibit binding to fc epsilon receptor I","volume":"157","author":"Wiegand","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/protein\/15.1.51","article-title":"A minimal receptor-Ig chimera of human FcepsilonRI alpha-chain efficiently binds secretory and membrane IgE","volume":"15","author":"Vangelista","year":"2002","journal-title":"Protein Eng."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.174.9.5602","article-title":"Membrane IgE binds and activates Fc epsilon RI in an antigen-independent manner","volume":"174","author":"Vangelista","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.13.3.420-422.2006","article-title":"Unreliable measurement of basophil maximum leukotriene release with the Buhlmann CAST 2000 enzyme-linked immunosorbent assay kit","volume":"13","author":"Burastero","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/314268a0","article-title":"A hapten-specific chimaeric IgE antibody with human physiological effector function","volume":"314","author":"Neuberger","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0155","first-page":"361","article-title":"Predicting protein crystallization from a dilute solution property","volume":"D50","author":"George","year":"1994","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0160","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1110\/ps.22901","article-title":"Role of conserved residues in structure and stability: tryptophans of human serum retinol-binding protein, a model for the lipocalin superfamily","volume":"10","author":"Greene","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(03)00925-6","article-title":"Conserved signature proposed for folding in the lipocalin superfamily","volume":"553","author":"Greene","year":"2003","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bbapap.2016.08.003_bb0170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaip.2014.09.004","article-title":"The allergic asthma phenotype","volume":"2","author":"Schatz","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00081","article-title":"New vaccines for mammalian allergy using molecular approaches","volume":"5","author":"van Hage","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0180","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1073\/pnas.0404735101","article-title":"Vaccination with genetically engineered allergens prevents progression of allergic disease","volume":"101","author":"Niederberger","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2016.08.003_bb0185","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.str.2015.10.011","article-title":"Perturbation of the conformational dynamics of an active-site loop alters enzyme activity","volume":"23","author":"Gagn\u00e9","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.bbapap.2016.08.003_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2013.07.024","article-title":"Structure of allergens and structure based epitope predictions","volume":"66","author":"Dall'Antonia","year":"2014","journal-title":"Methods"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916301595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916301595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T16:29:57Z","timestamp":1692462597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963916301595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1570963916301595"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.08.003","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The allergen Mus m 1.0102: Dissecting the relationship between molecular conformation and allergenic potency","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}